Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies M Kanekiyo, CJ Wei, HM Yassine, PM McTamney, JC Boyington, ... Nature 499 (7456), 102-106, 2013 | 899 | 2013 |
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection HM Yassine, JC Boyington, PM McTamney, CJ Wei, M Kanekiyo, ... Nature medicine 21 (9), 1065-1070, 2015 | 687 | 2015 |
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody D Corti, J Misasi, S Mulangu, DA Stanley, M Kanekiyo, S Wollen, ... Science 351 (6279), 1339-1342, 2016 | 423 | 2016 |
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera JO Ngwuta, M Chen, K Modjarrad, MG Joyce, M Kanekiyo, A Kumar, ... Science translational medicine 7 (309), 309ra162-309ra162, 2015 | 403 | 2015 |
Rational design of an Epstein-Barr virus vaccine targeting the receptor-binding site M Kanekiyo, W Bu, MG Joyce, G Meng, JRR Whittle, U Baxa, T Yamamoto, ... Cell 162 (5), 1090-1100, 2015 | 351 | 2015 |
Evaluation of candidate vaccine approaches for MERS-CoV L Wang, W Shi, MG Joyce, K Modjarrad, Y Zhang, K Leung, CR Lees, ... Nature communications 6 (1), 7712, 2015 | 342 | 2015 |
Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses MG Joyce, AK Wheatley, PV Thomas, GY Chuang, C Soto, RT Bailer, ... Cell 166 (3), 609-623, 2016 | 329 | 2016 |
High-throughput mapping of B cell receptor sequences to antigen specificity I Setliff, AR Shiakolas, KA Pilewski, AA Murji, RE Mapengo, K Janowska, ... Cell 179 (7), 1636-1646. e15, 2019 | 284 | 2019 |
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite NK Kisalu, AH Idris, C Weidle, Y Flores-Garcia, BJ Flynn, BK Sack, ... Nature medicine 24 (4), 408-416, 2018 | 273 | 2018 |
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses M Kanekiyo, MG Joyce, RA Gillespie, JR Gallagher, SF Andrews, ... Nature immunology 20 (3), 362-372, 2019 | 268 | 2019 |
Quadrivalent influenza nanoparticle vaccines induce broad protection S Boyoglu-Barnum, D Ellis, RA Gillespie, GB Hutchinson, YJ Park, ... Nature 592 (7855), 623-628, 2021 | 245 | 2021 |
Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages JRR Whittle, AK Wheatley, L Wu, D Lingwood, M Kanekiyo, SS Ma, ... Journal of virology 88 (8), 4047-4057, 2014 | 230 | 2014 |
Structural and molecular basis for Ebola virus neutralization by protective human antibodies J Misasi, MSA Gilman, M Kanekiyo, M Gui, A Cagigi, S Mulangu, D Corti, ... Science 351 (6279), 1343-1346, 2016 | 210 | 2016 |
Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on the Middle East respiratory syndrome coronavirus spike glycoprotein to avoid … L Wang, W Shi, JD Chappell, MG Joyce, Y Zhang, M Kanekiyo, ... Journal of virology 92 (10), 10.1128/jvi. 02002-17, 2018 | 182 | 2018 |
Immunization with components of the viral fusion apparatus elicits antibodies that neutralize Epstein-Barr virus in B cells and epithelial cells W Bu, MG Joyce, H Nguyen, DV Banh, F Aguilar, Z Tariq, ML Yap, ... Immunity 50 (5), 1305-1316. e6, 2019 | 149 | 2019 |
Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus AM Killikelly, M Kanekiyo, BS Graham Scientific reports 6 (1), 34108, 2016 | 146 | 2016 |
Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens G Ueda, A Antanasijevic, JA Fallas, W Sheffler, J Copps, D Ellis, ... Elife 9, e57659, 2020 | 144 | 2020 |
Activation dynamics and immunoglobulin evolution of pre-existing and newly generated human memory B cell responses to influenza hemagglutinin SF Andrews, MJ Chambers, CA Schramm, J Plyler, JE Raab, M Kanekiyo, ... Immunity 51 (2), 398-410. e5, 2019 | 128 | 2019 |
Design of nanoparticulate group 2 influenza virus hemagglutinin stem antigens that activate unmutated ancestor B cell receptors of broadly neutralizing antibody lineages KS Corbett, SM Moin, HM Yassine, A Cagigi, M Kanekiyo, ... MBio 10 (1), 10.1128/mbio. 02810-18, 2019 | 112 | 2019 |
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial KV Houser, GL Chen, C Carter, MC Crank, TA Nguyen, MC Burgos Florez, ... Nature medicine 28 (2), 383-391, 2022 | 108 | 2022 |